Navigating the Future: Cell Therapy Human Raw Materials Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cell Therapy Human Raw Materials Market Size Growth Forecast: What to Expect by 2025?
The market size for human raw materials in cell therapy has seen a substantial increase in recent years. The market value is projected to escalate from $2.82 billion in 2024 to a higher value of $3.39 billion in 2025, with a compounded annual growth rate (CAGR) of 20.4%. The market's expansion in the previous years can be linked to a higher incidence of chronic diseases, a surge in the elderly population, a great demand for restorative medicines, funds and support provided by the government, and an increase in healthcare costs.

How Will the Cell Therapy Human Raw Materials Market Size Evolve and Grow by 2029?
There is an anticipated surging growth in the market size of human raw materials for cell therapy in the coming years, with projections estimating its value reaching $7.05 billion by 2029. This progression, which is expected to exhibit a compound annual growth rate (CAGR) of 20.1%, can be ascribed to factors such as broadening therapeutic uses, heightened awareness among patients, supportive regulatory schemas, the expansion of the biopharmaceutical industry, and enhancements in manufacturing procedures. Looking forward to the forecast period, emerging trends include the adoption of allogeneic therapies, the implementation of artificial intelligence, a surge in ready-to-use cell therapies, utilization of 3D bioprinting technology, as well as the emergence of hybrid cell therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

What Drivers Are Propelling the Growth of Cell Therapy Human Raw Materials Market Forward?
The cell therapy human raw materials market's increased uptake is anticipated to be propelled by the growing acceptance of regenerative medicine. Regenerative medicine refers to the use of the body's own regenerative abilities or external stimuli such as stem cells, tissue engineering, or gene therapy to mend, replace, or regenerate damaged tissues and organs with the aim of restoring normal function. The visibility of regenerative medicine is increasing due to advancements in biotechnology, growing understanding of cellular mechanisms, increasing demand for personalized medicine, and the ability to effectively address unmet medical needs. Cell therapy and human raw materials are crucial in supporting the growing acceptance of regenerative medicine as they provide the necessary biological components for cell-based treatments, leading to the production of regulated and reliable solutions for various medical conditions. For instance, the Alliance for Regenerative Medicine, a US-based non-profit organization, reported in August 2023 that the number of cell, gene, and tissue-engineering therapeutic developers worldwide increased by 101% to 2760 in Q1 2023, from 1369 in Q1 2022. As such, the growing acceptance of regenerative medicine is fuelling the cell therapy human raw materials market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp

Which Emerging Trends Are Transforming the Cell Therapy Human Raw Materials Market in 2025?
Trend 1

Key cell therapy human raw materials market players are devoting their resources to devising chemically defined cell culture mediums, which are paving the way for faster development in cell therapy. A cell culture medium is a solution loaded with vital nutrients, growth stimulants, and conditions conducive to cell growth and propagation outside their natural milieu. For instance, a significant progression in this field was made by Lonza Group AG, a Swiss healthcare manufacturing firm, that introduced TheraPEAK T-VIVO Cell Culture Medium in May 2023. This unveiling includes a chemically defined, serum-free, animal component-free construct, along with recombinant proteins and enhanced support for culture and expansion. It also offers application aid to ensure uniformity, security, and strict adherence to regulations in cell therapy production. This medium, with its absence of animal components, chemically defined makeup, and regulatory-friendly features, signifies a crucial technological leap, thereby bolstering safety, quality, and regulatory compliance.

What Are the Key Segments in the Cell Therapy Human Raw Materials Market?
The cell therapy human raw materials market covered in this report is segmented -

1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions

Subsegments:
1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)
2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum
3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides
4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants
5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15759&type=smp

Who Are the Key Players Shaping the Cell Therapy Human Raw Materials Market's Competitive Landscape?
Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.

What Geographic Markets Are Powering Growth in the Cell Therapy Human Raw Materials Market?
North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15759

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.